Medication info
Nexium 40 mg Tablet (Esomeprazole Magnesium Trihydrate)

Nexium 40 mg Tablet (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Trihydrate›43.38mg / 1 tabletEsomeprazole Magnesium Dihydrate›43.38mg / 1 tablet
Manufacturer / importer
Allico Pharmaceutical Co., Ltd.
Appearance
For domestic use: Pink round enteric-coated tablets, For export: Pink round film-coated tablets
Packaging
Domestic - 28 tablets/box [14 tablets/Alu-Alu×2], Domestic - 30 tablets/bottle, Export - 28 tablets/box [14 tablets/Alu-Alu×2]
Approval status
Active

MFDS item code 201508405 · Approved 2015.12.23 · Insurance code 656004070

Summary

Main use
Treatment and prevention of reflux disease, gastrointestinal disorders (ulcers, symptoms, H. pylori eradication, etc.), and Zollinger-Ellison syndrome
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Adults Gastroesophageal reflux disease (GERD) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Combination therapy with antibiotics for eradication of Helicobacter pylori Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning) associated with NSAID (nonselective or selective COX-2 inhibitor) use 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Patients requiring continued NSAID therapy Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous administration to induce prevention of rebleeding due to gastric or duodenal ulcers. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. Older adults No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.

Ingredients

Manufacturer
Allico Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of reflux disease, gastrointestinal disorders (ulcers, symptoms, H. pylori eradication, etc.), and Zollinger-Ellison syndrome

  • Gastroesophageal reflux disease
  • erosive esophagitis
  • esophagitis
  • duodenal ulcers
  • peptic ulcers
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • rebleeding of gastric ulcers
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease and erosive esophagitis and for preventing recurrence. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers associated with eradication therapy for Helicobacter pylori. In addition, it helps treat and prevent gastric and duodenal ulcers related to upper gastrointestinal symptoms that occur during NSAID use. It is also used for the treatment of Zollinger-Ellison syndrome and for preventing rebleeding from gastric or duodenal ulcers. Overall, it demonstrates excellent efficacy in the treatment and management of gastrointestinal diseases.

Dosage and Administration

Adult dosage

This medicine should be swallowed with a liquid such as water and should not be chewed or crushed. Adults Gastroesophageal reflux disease (GERD) Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Combination therapy with antibiotics for eradication of Helicobacter pylori Administer 20 mg of this medicine with 1 g of amoxicillin and 500 mg of clarithromycin twice daily for 7 days. Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, and burning) associated with NSAID (nonselective or selective COX-2 inhibitor) use 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting longer than 4 weeks have not been conducted. Patients requiring continued NSAID therapy Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into two doses. Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following intravenous administration to induce prevention of rebleeding due to gastric or duodenal ulcers. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal impairment. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. Do not exceed a dose of 20 mg in patients with severe hepatic impairment. Older adults No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should continue treatment for an additional 4 weeks. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Adolescents aged 12 years and older — Gastroesophageal reflux disease (GERD), symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be taken once daily as needed. As-needed administration to control recurrent symptoms is not recommended for patients at high risk of gastric or duodenal ulcers due to NSAID use. Children under 12 years of age — There is no experience with administering this medicine to children under 12 years of age.

Precautions

This medication should not be used by patients with allergies or hypersensitivity to specific ingredients. Also, caution is needed as there may be side effects or interactions when taken with certain antibiotics or antivirals. Women who are breastfeeding and patients with a history of heart disease should avoid taking this medication. This medication contains lactose, making it unsuitable for patients with lactose intolerance. While taking this medication, various side effects such as headache, abdominal pain, diarrhea, and dizziness may occur; if symptoms are severe or persistent, consult a doctor immediately. Long-term use may require regular testing such as blood tests or monitoring magnesium levels. This medication can slightly increase the risk of bacterial infections in the gastrointestinal tract by lowering acidity, so inform your healthcare provider if diarrhea symptoms do not improve. Long-term use may increase the risk of fractures, so patients at risk for osteoporosis should exercise caution. This medication may interact with other medications, so be sure to inform your doctor or pharmacist if you are taking other medications. During pregnancy, the safety of this medication has not been fully established, so it should be taken only under the guidance of a doctor when necessary. In case of overdose, there are no specific antidotes; appropriate treatment should be provided according to symptoms, and it is important to keep it out of children's reach.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, retrosternal chest pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsened constipation, dyspepsia, dysphagia, gastrointestinal functional disorder, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccup, melena, oral disorder, pharyngeal disorder, rectal disorder, gastrointestinal symptoms, increased serum gastrin, tongue disorder, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, worsened arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, worsened depression, hypertonia, sensory loss, erectile dysfunction, insomnia, migraine, worsened migraine, sleep disorder, tremor, visual field defect, dysmenorrhea, menstrual disorders, vaginitis, worsened asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, dysosmia, taste loss, taste distortion, abnormal urination, albuminuria, cystitis, dysuria, fungal infection, hematuria, urination frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, gastric fundic polyp, hypocalcemia, hypokalemia, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to store it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

For domestic use: Pink round enteric-coated tablets, For export: Pink round film-coated tablets

Package unit

Domestic - 28 tablets/box [14 tablets/Alu-Alu×2], Domestic - 30 tablets/bottle, Export - 28 tablets/box [14 tablets/Alu-Alu×2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.